Firefly Neuroscience Inc (AIFF)

$2.08 +0.03 (1.46%)
Market Cap 27.97M
Revenue (ttm) 110,000.00
Net Income (ttm) -10.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,509.09%
Debt to Equity Ratio 0.00
Volume 196,600
Avg Vol 2,103,640
Day's Range N/A - N/A
Shares Out 13.45M
Stochastic %K 13%
Beta 2.11
Analysts Strong Buy
Price Target N/A

Company Profile

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serv...

Industry: Software - Application
Sector: Technology
Phone: 888 237 6412
Address:
1100 Military Road, Kenmore, United States
elgreg_2002
elgreg_2002 Oct. 25 at 5:18 PM
$AIFF Firefly Neurosciences’ stock drop is mainly due to uncertainty over potential dilution. The board’s proposal to issue more shares has raised concern because investors don’t yet know how many shares might be added or how the proceeds would be used. Without clarity, fears of reduced shareholder value outweigh optimism about growth plans. With the quarterly earnings report approaching, the market is waiting for concrete details—if management shows that any dilution supports revenue expansion, technology rollout, or partnerships, confidence could quickly rebound. Until then, uncertainty drives weakness. Bullish but concerned!
1 · Reply
isaacwilliams33
isaacwilliams33 Oct. 23 at 6:04 PM
$ZOOZ $RAYA <--still holding, $AIFF $INTJ :hotlist
0 · Reply
isaacwilliams33
isaacwilliams33 Oct. 22 at 7:59 PM
$ZOOZ $RAYA im still holding, might be good time to buy $AIFF $INTJ
0 · Reply
JayBirdEvans
JayBirdEvans Oct. 22 at 6:15 PM
$AIFF Need insiders to start buying 😩
0 · Reply
dcrown
dcrown Oct. 22 at 4:27 PM
$AIFF Tempus's expansion into neuroscience, as seen with its Northwestern University collaboration, could present a strategic overlap with Firefly's focus on neurological biomarkers
0 · Reply
SamGantVHee
SamGantVHee Oct. 22 at 4:04 PM
$AIFF averaging down under $2
0 · Reply
Helson
Helson Oct. 22 at 1:49 PM
$AIFF Wtf with this thing..
1 · Reply
JayBirdEvans
JayBirdEvans Oct. 21 at 8:58 PM
$AIFF Is this cooked?
0 · Reply
isaacwilliams33
isaacwilliams33 Oct. 20 at 6:01 PM
$SABS $INTJ $KIDZ $OPTT $AIFF new strategy
0 · Reply
isaacwilliams33
isaacwilliams33 Oct. 17 at 10:09 PM
$AIFF look for it to bottom near 2.40.
0 · Reply
Latest News on AIFF
Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

Sep 5, 2025, 7:55 AM EDT - 7 weeks ago

Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR' Platform

Aug 26, 2025, 7:45 AM EDT - 2 months ago

Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR' Platform

Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Jul 14, 2025, 7:45 AM EDT - 3 months ago

Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Firefly Neuroscience to be Added to the Russell Microcap® Index

Jun 23, 2025, 8:05 AM EDT - 4 months ago

Firefly Neuroscience to be Added to the Russell Microcap® Index

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients

Jun 20, 2025, 7:45 AM EDT - 4 months ago

Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

May 5, 2025, 9:00 PM EDT - 6 months ago

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

May 5, 2025, 7:45 AM EDT - 6 months ago

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Mar 6, 2025, 7:30 AM EST - 8 months ago

Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Feb 21, 2025, 8:00 AM EST - 8 months ago

Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

Firefly Neuroscience Accepted into NVIDIA Connect Program

Feb 11, 2025, 7:45 AM EST - 9 months ago

Firefly Neuroscience Accepted into NVIDIA Connect Program

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Feb 7, 2025, 7:30 AM EST - 9 months ago

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Jan 14, 2025, 12:25 PM EST - 10 months ago

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Jan 14, 2025, 7:45 AM EST - 10 months ago

Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Dec 31, 2024, 9:00 AM EST - 10 months ago

Firefly Neuroscience Closes on Financing of up to $12.4 Million

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Nov 14, 2024, 5:30 PM EST - 1 year ago

Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Nov 6, 2024, 9:00 AM EST - 1 year ago

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Oct 25, 2024, 4:10 PM EDT - 1 year ago

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Oct 16, 2024, 9:20 AM EDT - 1 year ago

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Oct 11, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience to Participate in Upcoming October Investor Conferences

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Sep 10, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Aug 26, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Aug 22, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

Aug 21, 2024, 9:00 AM EDT - 1 year ago

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

Aug 13, 2024, 4:06 PM EDT - 1 year ago

UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq

elgreg_2002
elgreg_2002 Oct. 25 at 5:18 PM
$AIFF Firefly Neurosciences’ stock drop is mainly due to uncertainty over potential dilution. The board’s proposal to issue more shares has raised concern because investors don’t yet know how many shares might be added or how the proceeds would be used. Without clarity, fears of reduced shareholder value outweigh optimism about growth plans. With the quarterly earnings report approaching, the market is waiting for concrete details—if management shows that any dilution supports revenue expansion, technology rollout, or partnerships, confidence could quickly rebound. Until then, uncertainty drives weakness. Bullish but concerned!
1 · Reply
isaacwilliams33
isaacwilliams33 Oct. 23 at 6:04 PM
$ZOOZ $RAYA <--still holding, $AIFF $INTJ :hotlist
0 · Reply
isaacwilliams33
isaacwilliams33 Oct. 22 at 7:59 PM
$ZOOZ $RAYA im still holding, might be good time to buy $AIFF $INTJ
0 · Reply
JayBirdEvans
JayBirdEvans Oct. 22 at 6:15 PM
$AIFF Need insiders to start buying 😩
0 · Reply
dcrown
dcrown Oct. 22 at 4:27 PM
$AIFF Tempus's expansion into neuroscience, as seen with its Northwestern University collaboration, could present a strategic overlap with Firefly's focus on neurological biomarkers
0 · Reply
SamGantVHee
SamGantVHee Oct. 22 at 4:04 PM
$AIFF averaging down under $2
0 · Reply
Helson
Helson Oct. 22 at 1:49 PM
$AIFF Wtf with this thing..
1 · Reply
JayBirdEvans
JayBirdEvans Oct. 21 at 8:58 PM
$AIFF Is this cooked?
0 · Reply
isaacwilliams33
isaacwilliams33 Oct. 20 at 6:01 PM
$SABS $INTJ $KIDZ $OPTT $AIFF new strategy
0 · Reply
isaacwilliams33
isaacwilliams33 Oct. 17 at 10:09 PM
$AIFF look for it to bottom near 2.40.
0 · Reply
BabaAlli
BabaAlli Oct. 17 at 8:04 PM
$AIFF next week we see 10
2 · Reply
elgreg
elgreg Oct. 15 at 2:05 AM
$AIFF You have done your do diligence or not! Do your research and you wibe an investor! Tune out the noise hang on for the journey
2 · Reply
Maverick7777777
Maverick7777777 Oct. 14 at 7:24 PM
$AIFF how did that workout?
1 · Reply
stacktwit
stacktwit Oct. 14 at 1:31 PM
https://www.stocktitan.net/sec-filings/AIFF/def-14a-firefly-neuroscience-inc-definitive-proxy-statement-e06b1a932a55.html "Firefly Neuroscience, Inc. (AIFF) is soliciting proxies for its 2025 Annual Meeting to be held virtually at 10:00 a.m. ET on October 27, 2025. The Board recommends votes FOR five proposals: elect two Class II directors (nominees Brian Posner and Stella Vnook), ratify appointment of Marcum as independent auditor for fiscal 2025, approve an amendment to the equity incentive plan to add 317,820 shares and an annual automatic increase (lower of 4% of outstanding common stock or Board-determined amount) from January 1, 2026 through January 1, 2035, authorize the Board to increase authorized shares up to an aggregate of 5,001,000,000 (including 1,000,000 preferred shares), and allow adjournment if needed to solicit additional proxies. Materials including the 2024 Form 10-K are available at www.proxyvote.com and the virtual meeting website" $AIFF
1 · Reply
stacktwit
stacktwit Oct. 14 at 1:21 PM
$AIFF The board of directors want to increase the amount of shares to 500,000,000 . I received an email from fidelity last week to vote on this.
0 · Reply
pajuosi
pajuosi Oct. 13 at 6:11 PM
$AIFF bouncing higher than i thought it would
0 · Reply
dcrown
dcrown Oct. 12 at 10:38 PM
$AIFF
0 · Reply
elgreg_2002
elgreg_2002 Oct. 10 at 8:33 PM
$AIFF Boy! The shorts have really ramped up their fear and panic machine! Baseless Law suits (scary law fire investigation) and now baseless posts claiming that the board of directors want to increase the amount of shares to 500,000,000 also untrue and designed to get you to sell cheap. They are desperate and greedy!
1 · Reply
elgreg_2002
elgreg_2002 Oct. 10 at 8:13 PM
$AIFF The tariff threat is and has from the beginning been the greatest con ever perpetrated in history, as it was always about grifting! Nothings changed! I guarantee this is Billionaires again making money off of volatility! Rinse and Repeat!
0 · Reply
Olg59
Olg59 Oct. 10 at 6:51 PM
$AIFF Got proxy today. They want to increase shares by 5-fold to 500Million .. Sold the last 200 shares today
0 · Reply
elgreg_2002
elgreg_2002 Oct. 10 at 4:15 PM
$AIFF This kind of hit piece unfortunately has become standard operating procedure for shorts to attack share price! I guess the share price of Firefly had moved to much to the upside! It costs very little to file a law suit which states that your law firm is going to look into corporate impropriety. Don’t be fooled this art is pure propaganda perioid!
0 · Reply
stacktwit
stacktwit Oct. 10 at 3:57 PM
$AIFF I hope for all our sakes this is the case.
0 · Reply